The Medical Letter on Drugs and Therapeutics
Issue 1515
Auvi-Q Epinephrine Auto-Injector Returns; Crisaborole (Eucrisa) for Atopic Dermatitis; Anticoagulation of Elderly Patients at High Risk for Falls with Atrial Fibrillation; Extended-Release Calcifediol (Rayaldee) for Secondary Hyperparathyroidism; Kyleena - Another Hormonal IUD; Drug Interaction: Clopidogrel and PPIs; Atezolizumab (Tecentriq) for Bladder Cancer and NSCLC (online only)
The full issue is available to subscribers Subscriber Login   
Auvi-Q Epinephrine Auto-Injector Returns

Auvi-Q (Kaléo; previously manufactured and marketed by Sanofi), the epinephrine auto-injector approved by the FDA in 2012 for emergency treatment of anaphylaxis and voluntarily withdrawn in 2015 due to potential inaccurate dosage delivery,1 has become available once more. According to Kaléo, improvements in the manufacturing process have addressed the concerns that led to its recall.

THE DEVICE — No changes were made to the device itself, which is about the length and width of a credit card and as thick as a smartphone. It has an automatic needle retraction system and a red safety guard at the needle-end of the device. Removal of the outer case initiates visual signals and an audio recording that provides step-by-step instructions and a 5-second countdown during the injection process. The shelf-life of the epinephrine in the auto-injector is 18 months; ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this issue:
Title: Issue 1515
Select version:
 Downloadable, electronic issue - $35
 Postal, hardcopy issue - $35